Long-Term Follow-Up of Spontaneous Retinal Pigment Epithelium Tears in Age-Related Macular Degeneration Treated with Anti-VEGF Therapy

Sebastian P. Lesniak, Howard F. Fine, Jonathan L. Prenner, Daniel B. Roth

European Journal of Ophthalmology · 2010 · 17 citations · 8 references

Concepts

Abstract

PURPOSE: To describe the clinical response following anti-vascular endothelial growth factor (VEGF) therapy in patients with spontaneous retinal pigment epithelium (RPE) tears secondary to age-related macular degeneration (AMD). METHODS: Retrospective chart review of patients with AMD who developed a spontaneous RPE tear and were subsequently treated with anti-VEGF therapy at a single institution. RESULTS: In 5 patients included in the study, the median number (range) of injections received was 14.2 (5-18). The median baseline acuity was 20/200, which remained stable at 12 months and improved to 20/60 at 24 months. These changes were not statistically different. CONCLUSIONS: Anti-VEGF therapy appears safe in eyes with spontaneous RPE tear secondary to AMD and may help to stabilize or even improve acuity in some cases.

References

8